GlassScriptPhysician profile
Michelle H Prickett
NPI 1821259995
$39,983.27
in general payments reported to CMS, 2019-2025
14 companies · $25K in 2025
The $25K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $11.94 · 2022: $23.12 · 2023: $4,423 · 2024: $10K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Education: $4,200 · Travel and Lodging: $940 · Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,133.00 |
| Education | $4,200.00 |
| Travel and Lodging | $940.35 |
| Food and Beverage | $572.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $20,990.07 | 2024-2025 | Arikayce, Brinsupri |
| Becton, Dickinson and Company | $14,300.00 | 2023-2024 | |
| Baxter Healthcare | $4,200.00 | 2025 | Hillrom - Volara System |
| Abbvie INC. | $170.11 | 2022-2025 | |
| Viatris Specialty LLC | $136.01 | 2025 | Tobi Podhaler |
| Advanced Respiratory, INC | $46.96 | 2019 | |
| Hill-Rom Company, INC | $28.33 | 2019 | |
| Melinta Therapeutics, LLC | $26.85 | 2024 | Rezzayo, Vabomere |
| Genzyme Corporation | $23.50 | 2024 | |
| Philips North America LLC | $22.80 | 2023 | |
| Allergan, INC. | $13.88 | 2019 | |
| Glaxosmithkline, LLC. | $12.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.94 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Prickett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.